1. Home
  2. EARN vs QTRX Comparison

EARN vs QTRX Comparison

Compare EARN & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.27

Market Cap

169.8M

Sector

Real Estate

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.19

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
QTRX
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
169.8M
160.0M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
EARN
QTRX
Price
$4.27
$3.19
Analyst Decision
Buy
Hold
Analyst Count
2
2
Target Price
$5.38
$6.00
AVG Volume (30 Days)
351.3K
835.8K
Earning Date
06-16-2026
05-06-2026
Dividend Yield
20.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$37,632,000.00
Revenue This Year
$7.69
$25.49
Revenue Next Year
$19.57
$10.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
64.52
52 Week Low
$4.10
$2.15
52 Week High
$5.73
$8.77

Technical Indicators

Market Signals
Indicator
EARN
QTRX
Relative Strength Index (RSI) 44.47 57.03
Support Level N/A $2.89
Resistance Level $4.49 $3.25
Average True Range (ATR) 0.07 0.19
MACD -0.00 0.09
Stochastic Oscillator 49.84 92.68

Price Performance

Historical Comparison
EARN
QTRX

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co The Fund is focused on acquiring and actively managing a portfolio of corporate CLOs, mainly mezzanine debt and equity tranches, which are typically collateralized by portfolios consisting mainly of below-investment-grade senior secured loans with a large number of discrete underlying borrowers across various industry sectors. Additionally, the Fund may also invest in CLO loan accumulation facilities, which are entities that acquire corporate loans and other similar corporate credit-related assets in anticipation of ultimately collateralizing a CLO transaction. The company's primary investment objectives are to generate attractive current income and risk-adjusted total returns for shareholders.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: